Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

AGM Statement

25 Jun 2024 07:00

RNS Number : 6762T
Anpario PLC
25 June 2024
 
Anpario plc("Anpario", "Group" or the "Company")

 

AGM Statement

 

 

Anpario plc, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, is holding its AGM later today, at which Matthew Robinson, Chairman, will make the following statement:

 

"The Group has delivered a strong sales performance and a corresponding improvement in profit in the first half of the year as the global agriculture market continues to improve and we are confident of achieving market expectations for the full year. There are still challenges to navigate and as highlighted at the time of our 2023 full year results announcement on 20 March 2024, we expected individual territory performance to be variable. In contrast to the strong first half performances last year in the United States and Australia, both territories have experienced weaker trading in the current period. However, all other regions have delivered strong sales growth with notable performances from Asia Pacific, Middle East and Africa and South America, demonstrating the resilience afforded by our geographic diversity.

 

The Group's business development initiatives are centred around expanding in the ruminant and aquaculture sectors as well as working with several partners in pet food where we can offer natural sustainable solutions. Our unique water-soluble phytogenic product Orego-Stim® Forte, for aquatic species, continues to show excellent field trial results, especially for inhibiting the growth of Vibrio species of bacteria in the absence of antibiotics. As such we are experiencing strong interest for this product from across the aquaculture industry.

 

Raw material prices have stabilised and together with increased volumes through our highly automated production facility we are delivering improved gross margins and profitability. Our cash position has improved further since the year end, with a balance of £12.2m as at 31 May 2024, giving us a strong financial position with which to continue to grow the business, both organically and through acquisitions, should the right opportunities arise."

 

The Company's interim results for the six months period ended 30 June 2024 are expected to be announced on 11 September 2024. 

 

 

 

Enquiries

 

Anpario plc

Richard Edwards, Chief Executive Officer

+44(0)7776 417 129

Marc Wilson, Group Finance Director

+44(0)1909 537 380

Shore Capital

 

(Nominated Adviser and Broker)

+44 (0) 20 7408 4090

Stephane Auton

Corporate Advisory

David Coaten

Tom Knibbs

Henry Willcocks

Corporate Broking

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFLTREISFIS
Date   Source Headline
21st Apr 20157:00 amRNSThe Queen's Award for Enterprise
16th Apr 20158:30 amRNSHolding(s) in Company
24th Mar 20154:24 pmRNSHolding(s) in Company
19th Mar 20154:51 pmRNSBlock Listing Application
18th Mar 20152:35 pmRNSHolding(s) in Company
17th Mar 20153:33 pmRNSIssue of Equity
10th Mar 20151:33 pmRNSDirector/PDMR Shareholding
4th Mar 20157:00 amBUSFinal Results
2nd Feb 20157:00 amRNSTrading Statement
23rd Jan 201510:00 amRNSBlocklisting Interim Review
8th Jan 20154:58 pmRNSHolding(s) in Company
14th Oct 20147:00 amRNSAgreement with Probiotics
6th Oct 20143:16 pmRNSTransaction in Own Shares
17th Sep 20144:31 pmRNSTransaction in Own Shares
11th Sep 20144:37 pmRNSDirector/PDMR Shareholding
10th Sep 20147:00 amBUSHalf-yearly Report
28th Aug 20144:20 pmBUSHolding(s) in Company
14th Jul 20143:02 pmRNSBlock Listing Application
14th Jul 20143:00 pmRNSBlock Listing Application
3rd Jul 20149:26 amBUSHolding(s) in Company
30th Jun 201410:55 amBUSHolding(s) in Company
25th Jun 20144:09 pmBUSHolding(s) in Company
24th Jun 20144:20 pmBUSResult of AGM
24th Jun 20143:36 pmBUSHolding(s) in Company
24th Jun 20147:00 amRNSTrading Statement
12th Jun 201412:03 pmBUSHolding(s) in Company
9th Jun 201411:54 amBUSDirector/PDMR Shareholding
5th Jun 201410:03 amBUSIssue of Equity
20th May 20143:12 pmBUSHolding(s) in Company
12th May 20147:00 amBUSAnnual Financial Report
15th Apr 20144:09 pmBUSHolding(s) in Company
9th Apr 20149:48 amBUSHolding(s) in Company
2nd Apr 20147:00 amBUSFinal Results
24th Feb 20147:00 amRNSAppointment of Peel Hunt as Nomad and Broker
3rd Feb 20147:00 amBUSTrading Statement
28th Jan 20147:00 amRNSDirector's Dealings
27th Jan 201412:06 pmBUSIssue of Equity
17th Jan 20145:10 pmBUSDirector/PDMR Shareholding
14th Jan 20144:39 pmBUSHolding(s) in Company
9th Jan 20147:01 amBUSDirector/PDMR Shareholding
9th Jan 20147:00 amRNSTrading in line with expectations
12th Dec 201310:07 amBUSHolding(s) in Company
6th Dec 20137:00 amRNSU.S. Office
28th Nov 20137:00 amRNSHolding(s) in Company
30th Oct 20133:27 pmRNSHolding(s) in Company
17th Oct 201312:45 pmBUSHolding(s) in Company
15th Oct 201311:31 amBUSHolding(s) in Company
14th Oct 20131:26 pmBUSHolding(s) in Company
30th Sep 20134:25 pmRNSIssue of Equity
27th Sep 20133:50 pmRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.